Register and share your invite link to earn from video plays and referrals.

Search results for moderna
moderna community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including moderna
Moderna Analyst Day: Details Strategic Shift Toward Oncology and Enhanced Production Capabilities.
Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas
Moderna on Friday smashed third-quarter revenue and earnings estimates and hiked its outlook for full-year sales growth, as some of its newer products gain momentum and Covid vaccine revenue outperforms. See more from the earnings report:
Show more
Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas
Moderna Q3 Earnings: - Rev: $1.31B (est $888.1M) - EPS: 38c (est loss/shr $1.09) - R&D Expenses: $583M (est $750M) - Total Operating Expenses: $1.18B (est $1.37B) - Cash & Cash Equivalents: $1.20B (est $1.37B) - Sees FY Capex: $200M (prev saw $200M To $300M; est $244.1M) - Sees FY R&D Expenses: About $2.7B (prev saw About $2.9B)
Show more
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
Moderna Earnings Preview: The Melanoma Breakthrough Is Real, But $221 Is Way Too Much $MRNA #business# #investing# #markets#
Moderna $MRNA setting its sights on the 2.618 🚀 $7 to give the platform a try. Ends tonight 👇
Moderna CEO Stephane Bancel said he believes the personalized mRNA cancer vaccine his company is developing with Merck & Co. will work in a variety of tumors, directly addressing a key issue shrouding the company’s future
Show more
Moderna CEO Stéphane Bancel calls the company’s cancer vaccine study with Merck a “landmark,” pointing to a 42% improvement compared with Keytruda alone. Bancel says Moderna is now focused on filing the drug with the FDA and believes it could be approved next year
Show more